Actively Recruiting
Study of Daily Pomegranate Juice Effects on Gut Inflammation, Quality of Life, and Gut Microbiome in Adults with Mild-to-Moderate Ulcerative Colitis
Led by University of California, Los Angeles · Updated on 2025-12-09
30
Participants Needed
2
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the effects of drinking 237 ml of pomegranate juice daily for 8 weeks on people with mild-to-moderate ulcerative colitis UC. The study aims to see if the juice can reduce gut inflammation and overall body inflammation, improve quality of life, and change the gut microbiome. This pilot trial will generate preliminary evidence on these effects by comparing groups over time. Participants will be randomly assigned to one of two groups for a 16-week study divided into two 8-week phases. In the first phase, one group drinks pomegranate juice daily while the other follows their usual diet. In the second phase, the groups switch the juice group stops drinking it and returns to their usual diet, and the other group begins drinking the juice daily. This crossover design helps assess the effects and any lasting impact after stopping juice consumption. During the study, participants will be assessed at the start, after 8 weeks, and after 16 weeks. Evaluations include clinical activity indexes, stool tests for gut inflammation, blood and urine tests for inflammation and oxidative stress markers, and analysis of gut microbiota and related metabolites. The study also monitors quality of life and uses these measurements to understand the impact of pomegranate juice on UC symptoms and gut health.
CONDITIONS
Brief Title
Effects of Pomegranate Juice on Ulcerative Colitis
Research Team
T
Tatiana Diacova, PhD, MS, RDN
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here